Position
BRAIDWELL LP in Monte Rosa Therapeutics, Inc.
Back to the book · All holders of GLUE
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $730.2K$15.68 → $16.45
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 948.3K | $14.9M | — | — | — | 0.5% |
| Q1 2026 | 3.21M | $52.7M | $16.45 | $730.2K | $37.1M | 1.8% |